Search Results - "FRANKEL, Arthur E"

Refine Results
  1. 1

    Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients by Frankel, Arthur E., Coughlin, Laura A., Kim, Jiwoong, Froehlich, Thomas W., Xie, Yang, Frenkel, Eugene P., Koh, Andrew Y.

    Published in Neoplasia (New York, N.Y.) (01-10-2017)
    “…This is the first prospective study of the effects of human gut microbiota and metabolites on immune checkpoint inhibitor (ICT) response in metastatic melanoma…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Autoimmune Bell's Palsy Following Immunotherapy For Metastatic Melanoma: A Report of 2 Cases by Zieman, Daniel, Frankel, Arthur E

    Published in Journal of immunotherapy (1997) (01-10-2019)
    “…By targeting receptors that serve to downregulate the cellular immune system, monoclonal antibodies such as ipilimumab and nivolumab have transformed the…”
    Get full text
    Journal Article
  4. 4

    Roles of the cGAS-STING Pathway in Cancer Immunosurveillance and Immunotherapy by Yum, Seoyun, Li, Minghao, Frankel, Arthur E, Chen, Zhijian J

    Published in Annual review of cancer biology (04-03-2019)
    “…Cyclic GMP-AMP synthase (cGAS) is a cytosolic DNA sensor that initiates innate immune responses. DNA-bound cGAS produces cyclic GMP-AMP (cGAMP), which…”
    Get full text
    Journal Article
  5. 5

    Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies by Alkharabsheh, Omar, Frankel, Arthur E

    Published in Biomedicines (05-01-2019)
    “…Overcoming the leukemia stem cell resistance to intensive chemotherapy has been an area of extensive research over the last two decades. Advances and greater…”
    Get full text
    Journal Article
  6. 6

    Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells by Khoury, Oula, Ghazale, Noura, Stone, Everett, El-Sibai, Mirvat, Frankel, Arthur E., Abi-Habib, Ralph J.

    Published in Journal of neuro-oncology (01-03-2015)
    “…In this study, we attempt to target Arginine auxotrophy in glioblastoma multiforme (GBM) cells using a pegylated recombinant human Arginase I cobalt [HuArgI…”
    Get full text
    Journal Article
  7. 7

    Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients by Frankel, Arthur E, Eskiocak, Ugur, Gill, Jennifer G, Yuan, Stacy, Ramesh, Vijayashree, Froehlich, Thomas W, Ahn, Chul, Morrison, Sean J

    Published in Neoplasia (New York, N.Y.) (01-04-2017)
    “…Abstract This is the first prospective study of a combination therapy involving a cardenolide and a MEK inhibitor for metastatic melanoma. Whereas BRAF mutant…”
    Get full text
    Journal Article
  8. 8

    Developing EZH2-Targeted Therapy for Lung Cancer by Frankel, Arthur E, Liu, Xin, Minna, John D

    Published in Cancer discovery (01-09-2016)
    “…Epigenetic targets are exciting new avenues for cancer drug discovery. Zhang and colleagues have designed the open-source EZH2 inhibitor JQEZ5 and shown…”
    Get more information
    Journal Article
  9. 9

    The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors by Alkharabsheh, Omar, Sidiqi, M Hasib, Aljama, Mohammed A, Gertz, Morie A, Frankel, Arthur E

    Published in Acta haematologica (01-03-2020)
    “…The gut microbiota plays a significant role in health and disease, including cancer development and treatment. The importance of the gut microbiota in the…”
    Get more information
    Journal Article
  10. 10

    Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota by Frankel, Arthur E., Deshmukh, Sachin, Reddy, Amit, Lightcap, John, Hayes, Maureen, McClellan, Steven, Singh, Seema, Rabideau, Brooks, Glover, T. Grant, Roberts, Bruce, Koh, Andrew Y.

    Published in Integrative Cancer Therapies (01-01-2019)
    “…The past decade has seen tremendous advances in both our understanding of cancer immunosuppressive microenvironments and colonic bacteria facilitated by immune…”
    Get full text
    Book Review Journal Article
  11. 11

    Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma by Frankel, Arthur E, Woo, Jung H, Ahn, Chul, Foss, Francine M, Duvic, Madeleine, Neville, Paul H, Neville, David M

    Published in Haematologica (Roma) (01-06-2015)
    “…Resimmune is a second-generation recombinant immunotoxin composed of the catalytic and translocation domains of diphtheria toxin fused to two single chain…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Red blood cell-encapsulated L-asparaginase: potential therapy of patients with asparagine synthetase deficient acute myeloid leukemia by Agrawal, Vaidehi, Woo, Jung Hee, Borthakur, Gautham, Kantarjian, Hagop, Frankel, Arthur E

    Published in Protein and peptide letters (01-04-2013)
    “…Red blood cell (RBC) encapsulated L-asparaginase is a novel therapeutic for the treatment of asparagine auxotrophic malignancies. The enzyme-loaded red blood…”
    Get more information
    Journal Article
  14. 14

    Tumor endothelial marker 8 promotes cancer progression and metastasis by Høye, Anette M, Tolstrup, Sofie D, Horton, Edward R, Nicolau, Monica, Frost, Helen, Woo, Jung H, Mauldin, Jeremy P, Frankel, Arthur E, Cox, Thomas R, Erler, Janine T

    Published in Oncotarget (10-07-2018)
    “…Every year more than 8 million people suffer from cancer-related deaths worldwide [1]. Metastasis, the spread of cancer to distant sites, accounts for 90% of…”
    Get full text
    Journal Article
  15. 15

    Regulation of HMGB1 release by autophagy by Thorburn, Jacqueline, Frankel, Arthur E., Thorburn, Andrew

    Published in Autophagy (16-02-2009)
    “…The characteristics of tumor cell killing by an anti-cancer agent can determine the long-term effectiveness of the treatment.  For example, if dying tumor…”
    Get full text
    Journal Article
  16. 16

    RLIP76 and Cancer by Awasthi, Sanjay, Singhal, Sharad S, Awasthi, Yogesh C, Martin, Bryan, Woo, Jung-Hee, Cunningham, C Casey, Frankel, Arthur E

    Published in Clinical cancer research (15-07-2008)
    “…RLIP76 is a multifunctional membrane protein that transports glutathione conjugates of electrophilic compounds and other xenobiotics including chemotherapy…”
    Get full text
    Journal Article
  17. 17

    Response to pegylated interferon in a COVID‐19 positive male with metastatic jejunal neuroendocrine tumor treated with everolimus by Frankel, Arthur E., Yip, Wai C., Naik, Eknath, Hasselbalch, Hans C.

    Published in Clinical case reports (01-06-2021)
    “…A 61‐year‐old male on everolimus had chronic SARS‐CoV‐2 infection. Addition of pegylated interferon cleared viral RNA and supports combination therapy with…”
    Get full text
    Journal Article
  18. 18

    Response to pegylated interferon in a COVID‐19–positive elderly woman with primary myelofibrosis treated with ruxolitinib by Frankel, Arthur E., Reddy, Renuka, DeSuza, Kayla R., Deeb, Khaled, Carlin, Aaron F., Smith, Davey, Xie, Yushuang, Naik, Eknath, Silver, Richard T., Hasselbalch, Hans C.

    Published in Clinical case reports (01-04-2021)
    “…An 83‐year‐old female had asymptomatic SARS‐CoV‐2 infection while taking ruxolitinib. She remained RT‐PCR positive for viral RNA for >120 days, and Pegylated…”
    Get full text
    Journal Article
  19. 19

    A STING-activating nanovaccine for cancer immunotherapy by Luo, Min, Wang, Hua, Wang, Zhaohui, Cai, Haocheng, Lu, Zhigang, Li, Yang, Du, Mingjian, Huang, Gang, Wang, Chensu, Chen, Xiang, Porembka, Matthew R., Lea, Jayanthi, Frankel, Arthur E., Fu, Yang-Xin, Chen, Zhijian J., Gao, Jinming

    Published in Nature nanotechnology (01-07-2017)
    “…STING-activating nanoparticle vaccines achieve robust activation of tumour-specific T cells for cancer immunotherapy. The generation of tumour-specific T cells…”
    Get full text
    Journal Article
  20. 20

    Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma by Eskiocak, Ugur, Ramesh, Vijayashree, Gill, Jennifer G., Zhao, Zhiyu, Yuan, Stacy W., Wang, Meng, Vandergriff, Travis, Shackleton, Mark, Quintana, Elsa, Frankel, Arthur E., Johnson, Timothy M., DeBerardinis, Ralph J., Morrison, Sean J.

    Published in Nature communications (29-09-2016)
    “…Nature Communications 7 Article number:12336 (2016); Published 22 August 2016; Updated 29 September 2016 Arthur E. Frankel, who helped to interpret the…”
    Get full text
    Journal Article